Harvest One is a global company that develops and distributes premium health, wellness and selfcare products with a market focus on sleep, pain, and anxiety. Harvest One is a uniquely positioned company in the cannabis space with a focus on cannabis infused and non-infused consumer packaged goods. Harvest One owns and operates three subsidiaries; Dream Water Global, Delivra (consumer) and Satipharm (medical and nutraceutical).
For more information, please visit www.harvestone.com
MMJ Group’s investment value in Harvest One Cannabis doubles in February
MMJ Investment Portfolio Update – Harvest One Cannabis
Harvest One Announces Agreement to Sell Satipharm for Approximately $4 Million and Imminent Completion of its Strategic Review Process
MMJ Group investee Harvest One continues international expansion through distribution agreement with China-based Golden River Services
Harvest One Continues International Expansion with Asian Distribution Agreement for Dream Water Products
MMJ Group investee Harvest One expands distribution of Dream Water Products in US
Harvest One Expands Distribution of Dream Water Products in the
United States and Internationally
Harvest One Expands Distribution for LivRelief Infused Topicals
Harvest One Reports Q1 2021 Financial Results and Provides Commercial Update
MMJ Group Holdings investee Harvest One gains US patent for proprietary Gellpell™ technology
Southern Cannabis operates three key businesses:
a) Cannabis Access Clinics was the first medical clinic network in Australia to recognize a need for speciality treatment alternatives such as medicinal cannabis. Working hand-in-hand with specialists in Addiction, Pain, Women’s Health and Psychiatry, we deliver on our whole of person philosophy of care.
b) Freshleaf Analytics which provides research into in the medicinal cannabis market in Australia.
c) Applied Cannabis Research which a leading Australian contract research organization focused exclusively on medicinal cannabis treatments
For more information, please visit southerncannabisholdings.com.au
Southern Cannabis Holdings Shareholder Presentation
Presentation from Southern Cannabis Holdings’ CEO, Tim Drury
Australia’s Southern Cannabis Holdings Expands Executive Team
Australia’s Southern Cannabis Holdings Launches Global Operations
Applied Cannabis Research and Cannabis Access Clinics approved to commence landmark PTSD study
Weed Me Inc. was established in April 2016. Founders Terry Kulaga and Benny Presman recognized the need for trustworthy Cannabis producers in the emerging Canadian cannabis market.
They aim to establish a vertically integrated cannabis company that leverages the company’s production facilities and clinical data to minimize operating costs while developing unique strains and formulations.
For more information, please visit weedme.ca
WeedMD Consolidates Medical Distribution Activities and Closes Facility to Maximize Production Efficiencies
MMJ Group investment Weed Me plans to expand facility capacity by 300%
Weed Me Investor Update
Weed Me announces completion of capital raising
Weed Me’s Shareholder Update
Martha Jane Medical is an Australian medicinal cannabis company focused on parallel strategies relating to its cultivation, supply, cannabinoid extraction, value added cannabis products and research and development of cannabis-based medicines. Their team is dedicated to developing safe, reliable and effective cannabinoid treatments supported by scientific verification for patients in Australia and internationally.
For more information, please visit marthajanemedical.com
Embark Health Inc is an extraction producer servicing the Canadian and Global medical and recreational markets. Providing cannabinoids and terpenes of the highest quality and consistency, while achieving significant production volumes.
For more information, please visit embarkhealthinc.com
Embark Delta Inc. Completes New Product Shipment to Province of British Columbia
Embark Health Inc. General Business Update to Shareholders
Embark Health – Investment Update
MMJ Group investee Embark Health enters into business combination agreement with Mesa Exploration Corp
Embark Health Investment Update
Embark Health – Investment Update
MMJ Group investee Embark Health completes acquisition of Canada-based Axiomm Technologies
MMJ Group Holdings investee Embark Health Inc continues delivering strategic priorities
Embark Health Inc. Announces Date of 2020 Annual and Special Meeting and Business Update
Embark Health – Investment Update
Vitagenne® is a global hemp-derived cannabidiol (CBD) consumer goods company providing wellness products across the U.S. and in international markets.
The Company’s mission is to be the leading supplier of branded hemp-derived CBD wellness products with an unwavering focus on quality and compliance to deliver the highest quality solutions to its customers. Proudly certified by the U.S. Hemp Authority™, Vitagenne exceeds stringent self-regulatory standards across all its products.
Vitagenne’s products are available for sale through its online e-commerce platform and its wholesale division.
For more information, please visit vitagenne.com
Sequoya Cannabis Ltd is a European CBD products manufacturer distinguishing itself by employing the highest production standards, incl. EU GMP and a facility lead by PhD scientists experienced in pharma, food & cosmetics formulations. This will enable Sequoya to service EU and global clients in cosmetics, food & beverage and pharmaceutical markets with the highest quality, EU standards and custom formulations for industry majors.
Based in Poland, its low cost production location and its own CBD retail brand (Sequoyalife), Sequoya Cannabis will establish an efficient, high standards based, vertically integrated company across Europe and globally.
For more information, please visit sequoya.ca
MMJ Group investee Sequoya sets scene for strong 2021 with focus on Europe
Sequoya Cannabis receives EU GMP Certification
Global Cannabis Provides Update to Exclusive Polish Sales Agreement with Sequoya Cannabis Ltd.
WeedMD Inc. is a federally-licensed producer and distributor of cannabis products for both the medical and adult-use markets.
WeedMD has a multi-channelled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies.
For more information, please visit weedmd.com
WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada
WeedMD Announces $15 Million Bought Deal Equity Financing
WeedMD Shareholder Newsletter:
2021 New Year – Great Expectations
MMJ Group investee WeedMD Inc reports 8% growth in net revenue quarter-over-quarter for the period ending September 30, 2020
WeedMD Reports Third Quarter 2020 Financial Results
WeedMD Investor Presentation – September 2020
WeedMD Advances Strategic Growth Initiatives in the Adult-Use Market with New Color Cannabis Offerings
WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX Industries
MMJ Investor Update – WeedMD
WeedMD to Report its Fiscal Year 2019 Financials on May 27, 2020
Bespoke Capital Acquisition Corp – Global brand focused special purpose investment company
• BCAC team led by Paul Walsh, former CEO of Diageo plc, the world’s largest spirits company, has strong track record in management of consumer products
• MMJ holds its investment in the Canadian listed BCAC entity (TSXV BC.U), through a limited partnership whose general partner is Bespoke Capital Partners LLC, which holds BCAC Founders Shares and Warrants, a class of security unavailable to retail investors
• MMJ’s investment in BCAC was sourced by EBV which includes warrants which provide potential upside following BCAC securing qualifying acquisitions
BevCanna Enterprises Inc. is an early leader in the emerging cannabis beverages market. Leveraging its unmatched beverage expertise, world-class infrastructure and proven technology, BevCanna develops and launches premium, innovative, cannabinoid-infused beverages that cater to the next generation of cannabis consumer.
In addition to producing infused beverages and building brands, BevCanna is also actively exploring brand acquisitions, strategic partnerships and joint venture opportunities.
For more information, please visit bevcanna.com
BevCanna’s monthly investor update
BevCanna Announces LOI to Acquire Cold-Pressed Juice Co. Little West
BevCanna Announces Exclusive Joint Venture and Manufacturing Agreement with Bloom
Bevcanna lays out goals for the next six months
BevCanna Signs Definitive Agreement with Higharchy Ventures to Create and Manufacture Cannabis Infused Beverages in Canada
BevCanna Signs Definitive Agreement for Outdoor Cannabis Cultivation
BevCanna Announces Exclusive Supply Agreement with Nextleaf Solutions for Water-Soluble Cannabinoids
BevCanna Signs Letter of Intent for 130 Acre Outdoor Cannabis Cultivation
BevCanna Awarded Health Canada Cannabis Research License
BevCanna Announces Successful Testing of Cannabis Powder Technology
Fire & Flower is a leading purpose-built, independent adult-use cannabis retailer poised to capture significant Canadian market share. The Company guides consumers through the complex world of cannabis through education-focused, best-in-class retailing while the Hifyre digital platform connects consumers with cannabis products. The Company’s leadership team combines extensive experience in the cannabis industry with strong capabilities in retail operations.
For more information, please visit fireandflower.com
Fire & Flower Achieves Milestone of 45 Cannabis Retail Stores Ahead of Projections
Fire & Flower Closes Transaction to Acquire 8 Additional Cannabis Retail Store Locations in Alberta
Fire & Flower Announces Second Quarter 2019 Financial and Operational Results
Fire and Flower, One of Canada’s Leading Independent Cannabis Retailers, CEO Clip Video
Fire & Flower Enters Into Definitive Agreements to Acquire 8 Additional Cannabis Retail Store Locations in Alberta
View from the C-Suite: Trevor Fencott, Fire & Flower CEO, tells his company’s story.
Corporate Presentation – July 2019
Fire & Flower Announces Strategic Investment by Alimentation Couche-Tard, Sets Sights on Global Cannabis Market and Conditional Approval to Uplist to the Toronto Stock Exchange
Fire & Flower Secures Agreement to Acquire Cannabis Store License of Regina, Saskatchewan and Enter Into Exclusive Supply Agreement
Fire & Flower Receives Cannabis Retail Store Licence for Lethbridge, Alberta
Founded in 2015, MediPharm Labs Inc. has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation license.
This expert focus on cannabis concentrates begins in its purpose-built laboratory designed to incorporate EUGMP (European Good Manufacturing Practices) workflow and ISO standard-built clean rooms and critical environments, allowing MediPharm Labs to produce purified, pharmaceutical-like cannabis oil and concentrates for advanced derivative products.
For more information, please visit medipharmlabs.com
MediPharm Labs Announces Participation at Upcoming Conferences
A Global Platform Powering a Global Market
MediPharm Labs Reaffirms Focus on Global Growth and Increases Cannabis 2.0 Shipments
MediPharm Labs Receives First GMP Certification, Now Permitted to Serve Global Medical Cannabis Market
MediPharm Labs Reports Strong, Profitable Third Quarter Results While Investing For Future Global Advantage
MediPharm Labs Submits Application to List on NASDAQ
MediPharm Labs Enters New Beverages and Culinary Lifestyle Market Through Cannabis Concentrate Supply Partnership with Tea and Edibles Company Olli Brands Inc.
MediPharm Labs Closes New $38.7 Million Up-sized Credit Facility with a Top 5 Canadian Schedule 1 Bank to Support Growth
MediPharm Labs Increases Exports of Medical Cannabis Concentrate to Australia
MediPharm Labs and TerrAscend Enter Major Private Label Concentrate Supply Agreement With Potential Value Up to $192 Million
Hemple is an Australian born brand that provides 100% natural Hemp & CBD products.
For more information, please visit hemple.com
Axiomm is an applicant licensed processor that is dedicated to developing and producing premium cannabis oils with terpene profiles as well as, when permitted, cutting-edge derivative products. Axiomm has developed an innovative way to dramatically improve the absorption of nutraceuticals, vitamins and cannabinoids by the human body through ingestion. Their technology enables a new level of effectiveness in incorporating nutraceuticals, vitamins and cannabinoids into beverages, edibles and topicals.
For more information, please visit bienventures.ca
Volero Brands is a privately held, British Columbia-based company engaged in the development of a family of cannabis brands and delivery systems for Canadian and international markets. The Company's flagship brand is Flyte, a suite of top-quality cannabis distillate products. The Flyte brand and expertise has been licensed in the state of Nevada for concentrates prepared from distillates of phytocannabinoids and packaged in vaporizer pen cartridges. The Company brings deep technical and brand expertise to extraction, formulation, development and marketing of cannabis distillate-based products.
For more information, please visit volero.ca